Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype
Open Access
- 16 May 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 11 (11) , 1263-1271
Abstract
Mutations in the EPM2A gene encoding a dual-specificity phosphatase (laforin) cause an autosomal recessive fatal disorder called Lafora's disease (LD) classically described as an adolescent-onset stimulus-sensitive myoclonus, epilepsy and neurologic deterioration. Here we related mutations in EPM2A with phenotypes of 22 patients (14 families) and identified two subsyndromes: (i) classical LD with adolescent-onset stimulus-sensitive grand mal, absence and myoclonic seizures followed by dementia and neurologic deterioration, and associated mainly with mutations in exon 4 (P=0.0007); (ii) atypical LD with childhood-onset dyslexia and learning disorder followed by epilepsy and neurologic deterioration, and associated mainly with mutations in exon 1 (P=0.0015). To understand the two subsyndromes better, we investigated the effect of five missense mutations in the carbohydrate-binding domain (CBD-4; coded by exon 1) and three missense mutations in the dual phosphatase domain (DSPD; coded by exons 3 and 4) on laforin's intracellular localization in HeLa cells. Expression of three mutant proteins (T194I, G279S and Y294N) in DSPD formed ubiquitin-positive cytoplasmic aggregates, suggesting that they were folding mutants set for degradation. In contrast, none of the three CBD-4 mutants showed cytoplasmic clumping. However, CBD-4 mutants W32G and R108C targeted both cytoplasm and nucleus, suggesting that laforin had diminished its usual affinity for polysomes. Our data, thus, represent the first report of a novel childhood syndrome for LD. Our results also provide clues for distinct roles for the CBD-4 and DSP domains of laforin in the etiology of two subsyndromes of LD.Keywords
This publication has 17 references indexed in Scilit:
- A Unique Carbohydrate Binding Domain Targets the Lafora Disease Phosphatase to GlycogenJournal of Biological Chemistry, 2002
- Mutation screening for Japanese Lafora's disease patients: identification of novel sequence variants in the coding and upstream regulatory regions of EPM2A geneMolecular and Cellular Probes, 2001
- Advances in the genetics of progressive myoclonus epilepsyAmerican Journal of Medical Genetics, 2001
- A mutation of the Wilson disease protein, ATP7B, is degraded in the proteasomes and forms protein aggregatesGastroenterology, 2001
- Mutational spectrum of the EPM2A gene in progressive myoclonus epilepsy of Lafora: high degree of allelic heterogeneity and prevalence of deletionsEuropean Journal of Human Genetics, 2000
- Characterization and Dynamics of Aggresome Formation by a Cytosolic Gfp-Chimera✪Journal of Cell Biology, 1999
- Aggresomes: A Cellular Response to Misfolded ProteinsJournal of Cell Biology, 1998
- Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsyNature Genetics, 1998
- Lafora Progressive Myoclonus Epilepsy: Narrowing the Chromosome 6q24 Locus by Recombinations and HomozygositiesThe American Journal of Human Genetics, 1997
- Axilla skin biopsy: A reliable test for the diagnosis of Lafora's diseaseAnnals of Neurology, 1987